Literature DB >> 23293395

Development of a PEG Derivative Containing Hydrolytically Degradable Hemiacetals.

Branden Reid1, Stephany Tzeng, Andrew Warren, Kristen Kozielski, Jennifer Elisseeff.   

Abstract

Entities:  

Year:  2010        PMID： 23293395      PMCID： PMC3534955          DOI： 10.1021/ma1020648

Source DB:  PubMed          Journal:  Macromolecules        ISSN： 0024-9297            Impact factor:   5.985


× No keyword cloud information.
  14 in total

Review 1.  Injectable matrices and scaffolds for drug delivery in tissue engineering.

Authors:  James D Kretlow; Leda Klouda; Antonios G Mikos
Journal:  Adv Drug Deliv Rev       Date:  2007-04-06       Impact factor: 15.470

Review 2.  Recent developments in cyclic acetal biomaterials for tissue engineering applications.

Authors:  Erin E Falco; Minal Patel; John P Fisher
Journal:  Pharm Res       Date:  2008-06-07       Impact factor: 4.200

3.  Synthesis and properties of cyclic acetal biomaterials.

Authors:  Jennifer L Moreau; Dafna Kesselman; John P Fisher
Journal:  J Biomed Mater Res A       Date:  2007-06-01       Impact factor: 4.396

Review 4.  Customized PEG-derived copolymers for tissue-engineering applications.

Authors:  Joerg K Tessmar; Achim M Göpferich
Journal:  Macromol Biosci       Date:  2007-01-05       Impact factor: 4.979

Review 5.  Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers.

Authors:  K A Athanasiou; G G Niederauer; C M Agrawal
Journal:  Biomaterials       Date:  1996-01       Impact factor: 12.479

Review 6.  Tissue engineering.

Authors:  R Langer; J P Vacanti
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

Review 7.  PEGylation, successful approach to drug delivery.

Authors:  Francesco M Veronese; Gianfranco Pasut
Journal:  Drug Discov Today       Date:  2005-11-01       Impact factor: 7.851

Review 8.  PEG hydrogels for the controlled release of biomolecules in regenerative medicine.

Authors:  Chien-Chi Lin; Kristi S Anseth
Journal:  Pharm Res       Date:  2008-12-18       Impact factor: 4.200

9.  Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice.

Authors:  T Yamaoka; Y Tabata; Y Ikada
Journal:  J Pharm Sci       Date:  1994-04       Impact factor: 3.534

10.  Cellular responses to degradable cyclic acetal modified PEG hydrogels.

Authors:  Sachiko Kaihara; Shuichi Matsumura; John P Fisher
Journal:  J Biomed Mater Res A       Date:  2009-09-01       Impact factor: 4.396
View more
  5 in total

Review 1.  Protein-polymer conjugation-moving beyond PEGylation.

Authors:  Yizhi Qi; Ashutosh Chilkoti
Journal:  Curr Opin Chem Biol       Date:  2015-09-07       Impact factor: 8.822

2.  PEG hydrogel degradation and the role of the surrounding tissue environment.

Authors:  Branden Reid; Matthew Gibson; Anirudha Singh; Janis Taube; Cecilia Furlong; Melissa Murcia; Jennifer Elisseeff
Journal:  J Tissue Eng Regen Med       Date:  2013-03-12       Impact factor: 3.963

3.  Determination of the in vivo degradation mechanism of PEGDA hydrogels.

Authors:  M B Browning; S N Cereceres; P T Luong; E M Cosgriff-Hernandez
Journal:  J Biomed Mater Res A       Date:  2014-02-13       Impact factor: 4.396

4.  Poly[(ethylene oxide)-co-(methylene ethylene oxide)]: A hydrolytically-degradable poly(ethylene oxide) platform.

Authors:  Pontus Lundberg; Bongjae F Lee; Sebastiaan A van den Berg; Eric D Pressly; Annabelle Lee; Craig J Hawker; Nathaniel A Lynd
Journal:  ACS Macro Lett       Date:  2012-10-10       Impact factor: 6.903

Review 5.  Therapeutic angiogenesis: controlled delivery of angiogenic factors.

Authors:  Hunghao Chu; Yadong Wang
Journal:  Ther Deliv       Date:  2012-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.